FDA Panel Narrowly Backs Merck's COVID Pill

Questions about efficacy, safety were chief among concerns, regardless of how members voted

Breaking News Alert Tuesday, November 30, 2021       FDA Panel Narrowly Backs Merck's COVID Pill   Questions about efficacy, safety were chief among concerns, regardless of how members voted   Read More   © 2021 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: edwardlorilla1986.acciyo123@blogger.com Manage Email Preferences   |    Unsubscribe   |   Terms of Use   |   Privacy Policy Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014